Literature DB >> 28643804

Diabetes: Why β cells fail in T2DM.

David Holmes.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28643804     DOI： 10.1038/nrendo.2017.82

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Sox5 regulates beta-cell phenotype and is reduced in type 2 diabetes.

Authors:  A S Axelsson; T Mahdi; H A Nenonen; T Singh; S Hänzelmann; A Wendt; A Bagge; T M Reinbothe; J Millstein; X Yang; B Zhang; E G Gusmao; L Shu; M Szabat; Y Tang; J Wang; S Salö; L Eliasson; I Artner; M Fex; J D Johnson; C B Wollheim; J M J Derry; B Mecham; P Spégel; H Mulder; I G Costa; E Zhang; A H Rosengren
Journal:  Nat Commun       Date:  2017-06-06       Impact factor: 14.919
  1 in total
  2 in total

1.  Trilobatin, a Natural Food Additive, Exerts Anti-Type 2 Diabetes Effect Mediated by Nrf2/ARE and IRS-1/GLUT2 Signaling Pathways.

Authors:  Yan-Ling Shi; Yue-Ping Zhang; Huan Luo; Fan Xu; Jian-Mei Gao; Jing-Shan Shi; Qi-Hai Gong
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

2.  S-Equol ameliorates insulin secretion failure through Chrebp/Txnip signaling via modulating PKA/PP2A activities.

Authors:  Ka Chen; Hedong Lang; Li Wang; Kai Liu; Yong Zhou; Mantian Mi
Journal:  Nutr Metab (Lond)       Date:  2020-01-14       Impact factor: 4.169
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.